Physician

Sridevi Challapalli, M.D.

According to 2025 Medicare claims, Sridevi Challapalli, M.D. (NPI: 1063404721) practices cardiology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is CHALLAPALLI CARDIOLOGY PC (NPI: 1487376166; TIN: 884018842) and primary practice location at 89511-2381. Challapalli is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Challapalli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,027 traditional Medicare patients, billed 8,155 HCPCS/CPT codes, and received $1,559,095 in Medicare payments. The top billing code was 78431 (Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan). Part D data shows 5,091 prescription claims across 819 beneficiaries totaling $935,695 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 52 claims. Open Payments data shows 94 records totaling $2,073. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $313,602 to $1,559,095. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $270,485 to $935,695. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,953 to $808.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,613	5,304	$313,602
2016	1,631	5,498	$311,635
2017	1,871	5,881	$310,869
2018	1,644	6,043	$321,114
2019	1,722	6,671	$402,922
2020	1,611	6,686	$385,772
2021	1,498	5,901	$374,766
2022	1,584	5,185	$308,436
2023	1,245	4,413	$319,385
2024	1,027	8,155	$1,559,095

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	440	4,578	$270,485
2016	535	5,526	$409,948
2017	660	5,881	$505,859
2018	753	6,531	$592,623
2019	814	6,856	$712,136
2020	869	7,731	$887,375
2021	867	7,420	$904,811
2022	836	6,816	$1,004,462
2023	801	5,787	$977,868
2024	819	5,091	$935,695

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	20	134	$18,135
2016	24	184	$14,523
2017	20	171	$7,894
2018	13	96	$5,179
2019	N/R	75	$4,244
2020	N/R	62	$3,611
2021	N/R	60	$4,132
2022	N/R	37	$2,505
2023	N/R	52	$2,705
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78431	Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan	468	471	$1,467
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	467	940	$412
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	504	527	$151
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	694	1,847	$91
J2785	Injection, regadenoson, 0.1 mg	466	1,876	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	257	18,345	$349,848
Repatha Sureclick	Evolocumab	97	6,056	$115,539
Jardiance	Empagliflozin	76	5,607	$105,040
Xarelto	Rivaroxaban	63	5,010	$90,896
Nexlizet	Bempedoic Acid/Ezetimibe	67	5,700	$71,952

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	94	$2,073	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sridevi Challapalli, M.D.?

Tedicare shows public-source Medicare data for Sridevi Challapalli, M.D. (NPI 1063404721), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sridevi Challapalli, M.D. have ACO affiliation data?

Sridevi Challapalli, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Sridevi Challapalli, M.D.?

Sridevi Challapalli, M.D. is linked to CHALLAPALLI CARDIOLOGY PC (billing NPI 1487376166) in the available physician profile data.

Does Sridevi Challapalli, M.D. have Open Payments data?

Sridevi Challapalli, M.D. has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.